Dyadic International (DYAI) Change in Cash (2018 - 2026)
Dyadic International (DYAI) posted Change in Cash of -$697771.0 for Q1 2026, up 46.42% sequentially from -$1.3 million in Q4 2025, and up 51.6% YoY from -$460257.5 in Q1 2025.
Dyadic International (DYAI) Change in Cash (2018 - 2026) Analysis & Trends
Dyadic International has reported Change in Cash for 9 years, with the latest figure at -$697771.0 in Q1 2026.
- Quarterly Change in Cash rose 51.6% year-over-year to -$697771.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90787.0 (up 101.65% YoY) and the FY2025 annual result came in at -$653251.0, down 7791.41% from the prior year.
- Change in Cash climbed to -$697771.0 in Q1 2026 per DYAI's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Change in Cash peaked at $4.1 million in Q1 2024 and troughed at -$4.4 million in Q2 2024.
- A 5-year average of -$623103.1 and a median of -$888148.0 in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2025: Change in Cash plunged 733.13% in 2024, then soared 1602.17% in 2025.
- Over 5 years, Change in Cash stood at -$944845.0 in 2022, then grew by 6.0% to -$888148.0 in 2023, then surged by 165.88% to $585136.0 in 2024, then sank by 322.56% to -$1.3 million in 2025, then surged by 46.42% to -$697771.0 in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$697771.0, -$1.3 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - | -697,771.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -697,771.00 |
| Dec 31, 2025 | -1.30 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -1.44 Mn |
| Dec 31, 2024 | 585,136.00 |
| Sep 30, 2024 | -211,784.00 |
| Jun 30, 2024 | -4.44 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Dec 31, 2023 | -888,148.00 |
| Sep 30, 2023 | 1.56 Mn |
| Jun 30, 2023 | -532,499.00 |
| Mar 31, 2023 | 579,818.00 |
| Dec 31, 2022 | -944,845.00 |
| Sep 30, 2022 | -2.74 Mn |
| Jun 30, 2022 | -2.94 Mn |
| Mar 31, 2022 | -3.33 Mn |
| Dec 31, 2021 | 2.09 Mn |
| Sep 30, 2021 | -358,215.00 |
| Jun 30, 2021 | 7.57 Bn |